Cargando…

Aberrant Expression of Histone Deacetylases 4 in Cognitive Disorders: Molecular Mechanisms and a Potential Target

Histone acetylation is a major mechanism of chromatin remodeling, contributing to epigenetic regulation of gene transcription. Histone deacetylases (HDACs) are involved in both physiological and pathological conditions by regulating the status of histone acetylation. Although histone deacetylase 4 (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Yili, Hou, Fei, Wang, Xin, Kong, Qingsheng, Han, Xiaolin, Bai, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5088184/ https://www.ncbi.nlm.nih.gov/pubmed/27847464 http://dx.doi.org/10.3389/fnmol.2016.00114

Ejemplares similares

Histone Deacetylase 6 and the Disease Mechanisms of α-Synucleinopathies
por: Lemos, Miguel, et al.
Publicado: (2020)

Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
por: Sanaei, Masumeh, et al.
Publicado: (2019)

The class II histone deacetylases as therapeutic targets for Parkinson’s disease
por: Mazzocchi, Martina, et al.
Publicado: (2020)

Histone deacetylases and their role in motor neuron degeneration
por: Lazo-Gómez, Rafael, et al.
Publicado: (2013)

Molecular mechanisms of histone deacetylases and inhibitors in renal fibrosis progression
por: Wang, Jiayu, et al.
Publicado: (2022)

Corroborating evidence for aberrant expression of histone deacetylase 8 in endometriosis
por: Zheng, Hanxi, et al.
Publicado: (2023)

Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, attenuates postoperative cognitive dysfunction in aging mice
por: Jia, Min, et al.
Publicado: (2015)

Histone Deacetylase Inhibitor Alleviates the Neurodegenerative Phenotypes and Histone Dysregulation in Presenilins-Deficient Mice
por: Cao, Ting, et al.
Publicado: (2018)

Histone Deacetylase Inhibitors Are Protective in Acute but Not in Chronic Models of Ototoxicity
por: Yang, Chao-Hui, et al.
Publicado: (2017)

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
por: Phimmachanh, Monica, et al.
Publicado: (2020)

Aberrant expression of histone deacetylase 8 in endometriosis and its potential as a therapeutic target
por: Zheng, Hanxi, et al.
Publicado: (2023)

Histone Deacetylases: Molecular Mechanisms and Therapeutic Implications for Muscular Dystrophies
por: Sandonà, Martina, et al.
Publicado: (2023)

Targeting Histone Deacetylases for Cancer Therapy: From Molecular Mechanisms to Clinical Implications
por: Li, Zhiming, et al.
Publicado: (2014)

Subcellular Localization of Class I Histone Deacetylases in the Developing Xenopus tectum
por: Guo, Xia, et al.
Publicado: (2016)

Histone deacetylase 10 structure and molecular function as a polyamine deacetylase
por: Hai, Yang, et al.
Publicado: (2017)

The Effects of Selective Inhibition of Histone Deacetylase 1 and 3 in Huntington’s Disease Mice
por: Hecklau, Katharina, et al.
Publicado: (2021)

Characterization of Histone Deacetylase Mechanisms in Cancer Development
por: Hai, Rihan, et al.
Publicado: (2021)

Beyond Histone and Deacetylase: An Overview of Cytoplasmic Histone Deacetylases and Their Nonhistone Substrates
por: Yao, Ya-Li, et al.
Publicado: (2011)

Targeting histone deacetylases for the treatment of disease
por: Lawless, M W, et al.
Publicado: (2009)

Histone deacetylases as targets for antitrypanosomal drugs
por: Zuma, Aline A, et al.
Publicado: (2018)

TMP21 in Alzheimer’s Disease: Molecular Mechanisms and a Potential Target
por: Qiu, Kaixin, et al.
Publicado: (2019)

Targeting histone deacetylases for cancer therapy: Trends and challenges
por: Liang, Tao, et al.
Publicado: (2023)

Astrocyte Reactivity Following Blast Exposure Involves Aberrant Histone Acetylation
por: Bailey, Zachary S., et al.
Publicado: (2016)

Histone Deacetylase Inhibition: An Important Mechanism in the Treatment of Lymphoma
por: Guo, Shan-qi, et al.
Publicado: (2012)

The Role and Mechanism of Histone Deacetylases in Acute Kidney Injury
por: Zhou, Xun, et al.
Publicado: (2021)

Histone Deacetylases Exert Class-Specific Roles in Conditioning the Brain and Heart Against Acute Ischemic Injury
por: Aune, Sverre E., et al.
Publicado: (2015)

Histone Deacetylases in the Pathogenesis of Diabetic Cardiomyopathy
por: Ke, Xiangyu, et al.
Publicado: (2021)

Neuronal Nitric Oxide Synthase in Neural Stem Cells Induces Neuronal Fate Commitment via the Inhibition of Histone Deacetylase 2
por: Jin, Xing, et al.
Publicado: (2017)

Taking Advantage of the Selectivity of Histone Deacetylases and Phosphodiesterase Inhibitors to Design Better Therapeutic Strategies to Treat Alzheimer’s Disease
por: Cuadrado-Tejedor, Mar, et al.
Publicado: (2019)

In vivo human brain expression of histone deacetylases in bipolar disorder
por: Tseng, Chieh-En J., et al.
Publicado: (2020)

Targeting Huntington’s disease through histone deacetylases
por: Gray, Steven G.
Publicado: (2011)

DNA and histone deacetylases as targets for neuroblastoma treatment
por: Stiborová, Marie, et al.
Publicado: (2010)

Targeting histone deacetylases in pancreatic ductal adenocarcinoma
por: Schneider, Günter, et al.
Publicado: (2010)

Histone deacetylase 6 structure and molecular basis of catalysis and inhibition
por: Hai, Yang, et al.
Publicado: (2016)

Histone deacetylases: revealing the molecular base of dimorphism in pathogenic fungi
por: Elías-Villalobos, Alberto, et al.
Publicado: (2015)

Chemical Phylogenetics of Histone Deacetylases
por: Bradner, James E., et al.
Publicado: (2010)

Histone deacetylases in viral infections
por: Herbein, Georges, et al.
Publicado: (2010)

Butyrate Histone Deacetylase Inhibitors
por: Steliou, Kosta, et al.
Publicado: (2012)

Histone deacetylase signaling in cardioprotection
por: Lehmann, Lorenz H., et al.
Publicado: (2013)

Histone deacetylase 6 in cancer
por: Li, Ting, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6s6l15cog7no3u1kn7isgf2cti